Prosecution Insights
Last updated: April 19, 2026

Sungkwang Medical Foundation

4 pending office actions

Portfolio Summary

4
Total Pending OAs
0
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18556783 MESENCHYMAL STEM CELLS HAVING ENHANCED OSTEOGENIC DIFFERENTIATION CAPACITY, AND USE THEREOF NGUYEN, NGHI V 1653 Non-Final OA Oct 23, 2023
18264521 METHOD FOR DIFFERENTIATING PLURIPOTENT STEM CELL-DERIVED HEMOGENIC ENDOTHELIAL CELLS INTO LYMPHOID LINEAGE CELLS WILSON, MICHAEL C 1638 Non-Final OA Aug 07, 2023
18042635 COMPOSITION FOR PROMOTING DIFFERENTIATION OF NEURAL STEM CELLS INTO DOPAMINERGIC NEURONS TINSLEY, BRENDAN THOMAS 1634 Non-Final OA Feb 23, 2023
17633960 METHOD FOR PREPARING MATRILIN-3 PRETREATED STEM CELL SPEROIDS, AND COMPOSITION, DERIVED THEREFROM, FOR PREVENTING OR TREATING CARTILAGE DISEASES MOSS, NATALIE M 1653 Non-Final OA Feb 09, 2022

Managing Sungkwang Medical Foundation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month